Læknablaðið : fylgirit - 01.07.1978, Side 91

Læknablaðið : fylgirit - 01.07.1978, Side 91
Analgesics. It appears that a drug must have anti- inflammatory properties before it can relieve pain in rheumatoid arthritis. Both pentazocine (Nuki et al,' 1973) and paracetamol (Lee et al, 1975 Lee et al, 1976) have been shown to be no more effective than placebo, even when given with an anti-inflammatory drug (Nuki et al, 1973, Lee et al, 1976). Approximately 40 per cent of our patients are prescribed paracetamol by their family doctor (Lee et al, 1974b) thus costing the British Health Service undue expense. Despite our efforts to indicate to our family practitioner colleagues there has been no diminution of the amount of paracetamol prescribed. Non-steroidal anti-inflammatory drugs other than aspirin. There are now a large number of such drugs available, and their principal pharmacological properties are summarised in Table I. Phenylbutazone and oxyphen- butazone, one of its two metabolites, have been used since the early fifties. Their potential list of side effects is breath taking, but of particular importance is bone marrow depression. Agranulocytosis and thrombocytopenia occur especially in younger people, and aplastic anaemia in elderly females (Inman, 1977). There is no doubt that these drugs are extremely useful and effective, but risk of bone marrow depression - albeit slight (1 in 80.000 prescriptions) - indicates that they should only be used after less toxic preparations have been tried. We no longer use these drugs to treat acute gout, since bone marrow depression occurs in 5 per cent of patients who have received treatment for less than one week (Fowler, 1972). There seems little to choose between phenylbutazone and oxyphenbutazone in terms of clinical efflcacy or toxic manifestations. The fenemates were introduced also in the 1950s. They are anthranilic acid derivatives, and the most popular one in the United Kingdom is mefenamic acid. Parke Davis, the maker of mefenamic acid claims that it is only a "weak analgesic", but trials we have recently done (Lee et al, 1976, Mavrikakis et al 1977) indicate that it is as potent as indomethacin and other non-steroidal drugs. Family doctors in Glasgow clearly have been influenced by adverts, for they only consider it a "weak analgesic" (Lee et al, 1974b). Side effects of the fenemates are relatively common, but most are mild. Dyspepsia is the more frequent complica- tion, and diarrhoea a close second. Rashes have been reported but clear on discontinuing therapy. Leucopenia, thrombocytopaenia and Coombs-positive haemolytic anaemia have also been described. Perhaps mefanamic acid has been somewhat underestimated and should be used more. Indomethacin is an indole derivative and continues to be a popular prescription of patients with rheumatoid arthritis, despite a high incidence of dyspepsia and cerebral symptoms. The drug has been accused of causing peptic ulceration, but a direct causal relationship has yet to be established. It is of interest that when probenecid is given with indomethacin much higher blood concentrations of the latter drug are found (Brooks et al, 1974). It is common for family doctors to prescribe two or even more non-steroidal anti-inflammatory drugs at the sametime, but the studies of Brooks at al (1975) have clearly shown that when indomethacin and aspirin are prescribed together their combined effect is no greater than either alone. There are now several propionic acid derivatives being used as non-steroidal anti-inflammatory analgesics. Ibuprofen was introduced in the 1960s by Boots Drug Company, and this has proved very popular. It is remarkably free from side effects, but it is not quite as potent as indomethacin (Deodhar et al, 1973). Flurbiprofen will shortly be released in the United Kingdom, and in our experience it promises to be more effective than ibuprofen (Lee et al, 1976). Naproxen was introduced in the 1970s by Syntex. It has the benefit that it only requires twice daily oral administration. Side effects are mild, but a few patients have been reported to have developed gastro- intestinal haemorrhage. Ketoprofen (May and Baker) is similar to ibuprofen in its effect and low incidence of side effects (Lee et al 1976). Fenoprofen has been 89
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104
Side 105
Side 106
Side 107
Side 108
Side 109
Side 110
Side 111
Side 112
Side 113
Side 114
Side 115
Side 116
Side 117
Side 118
Side 119
Side 120
Side 121
Side 122
Side 123
Side 124
Side 125
Side 126
Side 127
Side 128
Side 129
Side 130
Side 131
Side 132
Side 133
Side 134
Side 135
Side 136
Side 137
Side 138
Side 139
Side 140
Side 141
Side 142
Side 143
Side 144
Side 145
Side 146
Side 147
Side 148
Side 149
Side 150
Side 151
Side 152
Side 153
Side 154
Side 155
Side 156
Side 157
Side 158
Side 159
Side 160

x

Læknablaðið : fylgirit

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.